Cat.#: ACPP-1324
| Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1848 | Human MTPN Protein (AC1848) | 5 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1018 | Recombinant Human APLP2 Protein (6×His Tag) (AC1018) | 50 µg | inquiry |
| ACPP-1102 | Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102) | 50 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.